Malaria

Levels Of Antibodies At Liver Stage May Predict Resistance To Disease

Published in Medical Letter on the CDC and FDA, December 9th, 2001

High levels of antibodies against the liver stage of the malaria parasite appear to predict resistance to the disease say researchers from Brown University and the Seattle Biomedical Research Institute.

These findings could eventually lead to new strategies for malaria vaccines or treatments.

"Malaria occurs in stages in the human body," says Jonathan Kurtis, assistant professor of pathology and laboratory medicine at Brown University, and the lead author of the study. "In the first stage a low number of parasites invades the liver. This liver stage is not harmful. It's the second stage, the blood stage, where the clinical disease we know as...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2001-12-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry